Live Chat

交易 Bristol Myers BMY

BristolMyers實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期  關閉 更改 更改(%): 開倉

最新新聞

Christine Voong 2024 Dec 03, 10:28

原油價格回升,OPEC+會議與OPEC+減產計劃延長成為油市關注焦點

Christine Voong 2024 Dec 03, 08:25

美元強勢壓力下,黃金價格走勢微幅回升,市場聚焦聯準會政策與非農數據

Christine Voong 2024 Dec 03, 03:30

美股指數期貨走穩,科技股領漲,標普500指數與納斯達克綜合指數創新高

So Ze Dong 2024 Dec 02, 16:00

12月3日財經:美股指數再創新高,投資者靜待即將公布的經濟數據

Christine Voong 2024 Dec 02, 10:26

Wedbush預測科技股年底反彈,特斯拉股價將受川普政策推動加速增長

Christine Voong 2024 Dec 02, 08:50

比特幣價格走勢維持震盪,XRP市值躍升全球第三大貨幣,加密貨幣市場觀望政策走向

Christine Voong 2024 Dec 02, 04:28

賓士加碼投資Momenta公司,四款車型採用先進駕駛輔助系統(ADAS)應對中國市場挑戰

So Ze Dong 2024 Dec 02, 01:00

12月2日財經:11月美股表現亮眼,投資者觀望股市年底行情

聯絡方式

點差

0.38

點差(%)

0.6397 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場開放

星期二

14:31 - 20:59

星期一

14:31-20:59

星期三

14:31-20:59

星期四

14:31-20:59

星期五

14:31-20:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

121671606272

流通股份

2028179968

收益日期(下一個)

2001-08-07

現金殖利率 

2024-11-01

除息日

2024-10-04

遠期年股息率

2.4

遠期年現金殖利率

0.0405

每股盈餘

-3.58

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具
Trustpilot
Live Chat